ACTIVE

Bioqube Factory Fund II Privak

Export PDF

Financial year 2025 · Closed on 30/09/2025

Net result-60,8 k €
Gross margin-59,9 k €
Equity10,7 M €

Identity

Source · BCE/KBO

Bioqube Factory Fund II Privak is a Limited partnership incorporated in 2024. Its registered office is in Bruxelles.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 1016.385.497
Incorporation
19/11/2024
Legal form
Limited partnership
Registered office
Place des Barricades 13
1000 Bruxelles · BruxellesSee on map
Contributed capital
10 713 472,29 €
Latest accounts
30/09/2025
Signals
Solid equity

Financials

Source · NBB, 1 filing

Trend over 1 financial year

2025
Income statement
Gross margin-59,9 k €
EBITDA-60,3 k €
Operating result-60,3 k €
Net result-60,8 k €
Balance sheet
Equity10,7 M €
Total assets12,1 M €
Cash18,1 k €
Debts1,5 M €

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/09/2025

1 active

Active mandates

BQV Partners

Manager · since 18 novembre 2024 · 1010.291.226

Represented by Nico Vandervelpen

Active

Other companies at this address

Place des Barricades 13 1000 Bruxelles
CompanyCBE no.
ALBA HOLDING● Active
1038.846.046
ARMED CELL THERAPEUTICS● Active
1039.592.451
BIOQUBE FACTORY FUND I● Active
0747.784.678
Bioqube Factory Fund II Partnership● Active
1016.717.178
Domein van Vorselaar● Active
0423.793.790
EDWIN VERMULST● Active
0862.424.030
Fibrocor Therapeutics Europe● Active
1025.566.152
MERISANT EUROPE● Active
0471.239.064
Orgues De Facto● Active
0763.798.685
PETER KUGEL● Active
0607.848.520
Société Coopérative pour le Développement Industriel en Afrique● Liquidation
0400.488.749
Société des Habitations à Bon Marché● Liquidation
0403.363.117
Stoffels IMC● Active
0780.918.294
VIPOWA● Active
0886.120.437
VVGB 2016● Active
0654.806.418
VVGB Advocaten fv● Active
0525.904.504

Full financial information

Source · NBB
2025
Type of accountAbridged model
Start of the financial year18/11/2024
Closing of the financial year30/09/2025
Length of the financial year11 months
Filing date12/05/2026
General meeting20/03/2026
Currency of the financial yearEUR
NBB quality labelSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 1 filing
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/09/202520/03/202612/05/2026DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/09/2025

1 active

Active mandates

BQV Partners

Manager · since 18 novembre 2024 · 1010.291.226

Represented by Nico Vandervelpen

Active

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares19/08/2026
    Kapitaalverhoging
    PDF
  • Capital / shares13/08/2025
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares03/06/2025
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares19/03/2025
    KAPITAAL - AANDELEN
    PDF
  • Other25/11/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BOEKJAAR
    PDF
  • Other21/11/2024
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-60,8 k €
  2. 19/11/2024
    IncorporationLimited partnership